HCA Healthcare Q2 FY26 net income rises 2.8% to $1.7 billion; revenue climbs 8.7% to $20.23 billion
HCA Healthcare Inc
HCA Healthcare Inc HCA | 0.00 |
- HCA Healthcare previewed Q2 2026 results with revenue rising 8.74% to $20.23 billion.
- Net income attributable to shareholders increased 2.78% to $1.7 billion; diluted EPS climbed 11.57% to $7.62.
- Adjusted EBITDA rose 4.63% to $4.03 billion; adjusted EBITDA margin narrowed 0.8 percentage points to 19.9%.
- Payer mix shifted toward uninsured patients who lost exchange coverage, creating an estimated $400 million pre-tax hit; Medicaid supplemental programs added about $400 million net benefit.
- 2026 guidance was cut to net income of $6.3 billion-$6.7 billion on revenue of $77 billion-$79.5 billion; Sam Hazen cited a “dynamic environment” while backing digitization plans.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260714472051) on July 14, 2026, and is solely responsible for the information contained therein.
